Microglial-dependent neurodegeneration in multiple sclerosis is fueled by the pHERV-W envelope protein

被引:0
|
作者
Kremer, D. [1 ]
Gruchot, J. [1 ]
Weyers, V. [1 ]
Oldemeier, L. [1 ]
Goettle, P. [1 ]
Healy, L. [2 ]
Jang, J. Ho [2 ]
Xu, Y. Kang T. [2 ]
Volsko, C. [3 ]
Dutta, R. [3 ]
Trapp, B. [3 ]
Perron, H. [4 ]
Hartung, H. -P. [1 ]
Kuery, P. [1 ]
机构
[1] Heinrich Heine Univ, Dept Neurol, Dusseldorf, Germany
[2] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
[3] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA
[4] Geneuro, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T05-029A
引用
收藏
页码:E212 / E213
页数:2
相关论文
共 50 条
  • [1] Microglial-dependent neurodegeneration in multiple sclerosis is fueled by pHERV-W envelope protein
    Kremer, D.
    Gruchot, J.
    Weyers, V.
    Oldemeier, L.
    Goettle, P.
    Healy, L.
    Jang, J. H.
    Dutta, R.
    Trapp, B.
    Perron, H.
    Hartung, H. -P.
    Kuery, P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1000 - 1000
  • [2] pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis
    Kremer, David
    Gruchot, Joel
    Weyers, Vivien
    Oldemeier, Lisa
    Goettle, Peter
    Healy, Luke
    Jang, Jeong Ho
    Xu, Yu Kang T.
    Volsko, Christina
    Dutta, Ranjan
    Trapp, Bruce D.
    Perron, Herve
    Hartung, Hans-Peter
    Kuery, Patrick
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (30) : 15216 - 15225
  • [3] The antibodies against the pathogenic pHERV-W envelope protein and the Clinical Forms of Multiple Sclerosis
    Ruberto, Stefano
    Dominguez-Mozo, Maria
    Garcia-Martinez, Maria
    Antonio Sechi, Leonardo
    Alvarez-Lafuente, Roberto
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 875 - 875
  • [4] Correlation between antibodies against the pathogenic pHERV-W envelope protein and the inflammatory phase of multiple sclerosis
    Ruberto, Stefano
    Cossu, Davide
    Sechi, Leonardo A.
    IMMUNOLOGY, 2024, 171 (02) : 270 - 276
  • [5] Microglia-dependent neurodegeneration is fueled by HERV-W envelope protein in different mouse models of MS
    Gruchot, J.
    Leppert, D.
    Hartung, H-P
    Perron, H.
    Meyer, U.
    Kuery, P.
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (1_SUPPL)
  • [6] pHERV-W ENV/syncytin-1 expression in relapsing-remitting and primary progressive multiple sclerosis patients and healthy controls: differences and possible viral transactivation
    Perez-Perez, S.
    Dominguez-Mozo, M. I.
    Garcia-Martinez, M. A.
    Garcia-Frontini, M. C.
    Villarrubia, N.
    Costa-Frossard, L.
    Villar, L. M.
    Arroyo, R.
    Alvarez-Lafuente, R.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 366 - 366
  • [7] Human retrovirus pHEV-W envelope protein and the pathogenesis of multiple sclerosis
    Lisak, Robert P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (30) : 14791 - 14793
  • [8] On the origin of a pathogenic HERV-W envelope protein present in multiple sclerosis lesions
    Ruprecht, Klemens
    Mayer, Jens
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (40) : 19791 - 19792
  • [9] A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env
    Porchet, Nerve
    Vidal, Virginie
    Kornmann, Gabrielle
    Malpass, Sam
    Curtin, Francois
    CLINICAL THERAPEUTICS, 2019, 41 (09) : 1737 - 1746
  • [10] Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis
    Pistolesi, Alessandra
    Ranieri, Giuseppe
    Calvani, Maura
    Guasti, Daniele
    Chiarugi, Alberto
    Buonvicino, Daniela
    EXPERIMENTAL NEUROLOGY, 2025, 385